How is the MRC molecular haematology unit advancing haematology?
The MRC Molecular Haematology Unit (MHU) aims to understand how blood cells form, and what happens when the developmental processes and genes involved in blood formation are disrupted in blood diseases such as leukemias and thalassaemias. Located within the MRC Weatherall Institute of Molecular Medicine at the University of Oxford, the MHU brings together scientists and clinicians in the pursuit of connecting discoveries in molecular science to the treatment of blood disease.
Voiceover by Prof. Bethan Psaila, Associate Professor of Haematology
The Medical Research Council (MRC) Molecular Haematology Unit at the University of Oxford (MRC MHU) investigates the processes by which multipotential haemopoietic stem cells become committed and differentiate into the highly specialised cells found in the peripheral blood (red cells, granulocytes, lymphocytes and platelets). The MRC MHU studies how these processes are perturbed in acquired and inherited blood diseases (for example thalassaemia, myelodysplasia and leukaemias). MRC MHU research is closely integrated with the NHS, giving access to patients with haematological disease and clinical material, thus ensuring that the Unit’s scientific developments can be rapidly translated into improved clinical care.